Eradivir, Inc.
Eradivir is developing drugs that bind to diseased cells, serving as a beacon to guide the immune system.
)
January 11-14, 2027 | San Francisco
January 11-14, 2027 | San Francisco
)
)
January 11-14, 2027 | San Francisco
){kind=logo}
)